Cite
Clinical-CT mismatch defined NIHSS ≥ 8 and CT-ASPECTS ≥ 9 as a reliable marker of candidacy for intravenous thrombolytic therapy in acute ischemic stroke.
MLA
Wu, Hung-Ming, et al. “Clinical-CT Mismatch Defined NIHSS ≥ 8 and CT-ASPECTS ≥ 9 as a Reliable Marker of Candidacy for Intravenous Thrombolytic Therapy in Acute Ischemic Stroke.” PLoS ONE, vol. 16, no. 4, Apr. 2021, pp. 1–11. EBSCOhost, https://doi.org/10.1371/journal.pone.0251077.
APA
Wu, H.-M., Lee, I.-H., Luo, C.-B., Chung, C.-P., & Lin, Y.-Y. (2021). Clinical-CT mismatch defined NIHSS ≥ 8 and CT-ASPECTS ≥ 9 as a reliable marker of candidacy for intravenous thrombolytic therapy in acute ischemic stroke. PLoS ONE, 16(4), 1–11. https://doi.org/10.1371/journal.pone.0251077
Chicago
Wu, Hung-Ming, I-Hui Lee, Chao-Bao Luo, Chih-Ping Chung, and Yung-Yang Lin. 2021. “Clinical-CT Mismatch Defined NIHSS ≥ 8 and CT-ASPECTS ≥ 9 as a Reliable Marker of Candidacy for Intravenous Thrombolytic Therapy in Acute Ischemic Stroke.” PLoS ONE 16 (4): 1–11. doi:10.1371/journal.pone.0251077.